Sanofi (OTCMKTS:SNYNF – Get Free Report) was the recipient of a large decline in short interest in the month of June. As of June 15th, there was short interest totaling 167,782 shares, a decline of 39.1% from the May 31st total of 275,393 shares. Based on an average trading volume of 6,920 shares, the short-interest ratio is currently 24.2 days.
Sanofi Price Performance
Shares of Sanofi stock opened at $81.29 on Thursday. Sanofi has a fifty-two week low of $80.74 and a fifty-two week high of $106.34. The business’s fifty day moving average is $87.40 and its two-hundred day moving average is $91.52.
About Sanofi
Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.
In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.
Recommended Stories
- Five stocks we like better than Sanofi
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.
